Skip to main content

Table 2 Cardiovascular risk assessment in the NAFLD and control groups

From: A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with Non-alcoholic fatty liver disease

 

<10% (low)

10%-20% (intermediate)

>20% (high)

Controls (%) (n = 45)

88.6

11.4

0

NAFLD (%) (n = 50)

80

16

4

NAFLD and MS (%) (n = 50)

48

40

12

  1. NAFLD; Non-alcoholic fatty liver disease, MS; metabolic syndrome.
  2. EDD: Endothelium-dependent dilatation.
  3. EID: Endothelium-independent dilatation.
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us